Chennai, April 19, 2021: Caplin Point Laboratories Limited (BSE: CAPPL (524742), NSE: CAPLIPOINT) Caplin Steriles Limited (Caplin), a Subsidiary Company of Caplin Point Laboratories Limited, has been granted final approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Milrinone Lactate Injection USP, 10 mg/10 mL (1 mg/mL),…
as #36 India Companies Ranked by Value as #760 Global Companies Ranked by Value as # 759 in Global Pharma Companies Download
Madan Krishnan, Vice President, and MD, Indian Subcontinent, India Medtronic, said human capital is the asset adding to it, adoption of technology in a better way to achieve a goal of $5 trillion economy. The thriving automotive industry, flourishing digital economy, and the vast scope in academics are some of the X-factors of Tamil Nadu…
Sales rise 24.68% to Rs 240.08 crore. Net profit of Caplin Point Laboratories rose 8.56% to Rs 54.53 crore in the quarter ended June 2020 as against Rs 50.23 crore during the previous quarter ended June 2019. Sales rose 24.68% to Rs 240.08 crore in the quarter ended June 2020 as against Rs 192.55 crore…
Caplin Point laboratories expansion plan includes its foray into Bangladesh.Management at Caplin Point, Vivek Partheeban speaks to ET Now about theopportunities in some of the South East Asian countries, as far as the supply is concerned. Caplin Point laboratories deal with injectibles, which are used specifically in the hospitals. The foray into Bangladesh is more…
Caplin Point Laboratories Chairman C C Paarthipan said the company has partnered with Xellia which has a long standing track record of commercial success in the US for injectable products. (Representational image: Reuters) Drug firm Caplin Point Laboratories on Tuesday said its subsidiary has entered into a distribution agreement with Xellia Pharmaceuticals for five injectable…
CAPLIN STERILES SIGNS PACT WITH XELLIAPHARMACEUTICALS CAPLIN STERILES TO LICENSE 5 INJECTABLE ANDAS TOXELLIA APPROVAL FOR 4 PRODUCTS EXPECTED WITHIN NEXT 12-18 MONTHS Source text for Eikon. https://www.reuters.com/article/brief-caplin-point-laboratories-ltd-capl/brief-caplin-point-laboratories-ltd-caplin-steriles-gets-usfda-approval-for-verapamil-hydrochloride-injection-usp-idUKFWN2BI1O1
Sales decline 28.86% to Rs 100.12 crore. Net profit of Caplin Point Laboratories rose 24.38% to Rs 50.15 crore in the quarter ended March 2020 as against Rs 40.32 crore during the previous quarter ended March 2019. Sales declined 28.86% to Rs 100.12 crore in the quarter ended March 2020 as against Rs 140.74 crore…
Caplin Point Laboratories jumped 6% to Rs 374 after the drug maker received the final approval from the US drug regulator for its Abbreviated New Drug Application (ANDA) Phenylephrine Hydrochloride injection. Phenylephrine Hydrochloride injection is indicated for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia. The drug had…
Caplin Point jumps 6% on USFDA nod for local anesthesia. This is a generic therapeutic equivalent version of NAROPINInjection, of Fresenius Kabi USA LLC. Shares of Caplin Point Laboratories jumped over 6 percent after the company said it has been granted final approval from the United States Food and Drug Administration (USFDA) for its RopivacaineHydrochloride…
